# Gentex Corporation (GNTX) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Consumer Cyclical / Auto Parts. Price $20.09, market value $4.2 billion.

## Valuation
- **P/E (trailing): 10.7×** (5-yr avg 17.2×, 3-yr avg 15.3×). Gentex Corporation trades at 10.7× trailing earnings, well below its own five-year average of 17.2×: cheap by its own standards. The Consumer Cyclical median in the September 2026 study was 19.5×. Forward P/E is 9.4×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 1.6×**. Each dollar of revenue is priced at 1.6×.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 6.7×**. Enterprise value is 6.7× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 11.7%** (5-yr avg 5.4%). Free cash flow equals 11.7% of the market value, above its five-year average of 5.4%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 9.3%**. The inverse of the P/E: 9.3% of the price is earned each year.

## Profitability
- **Gross margin: 35.0%**. Gentex Corporation keeps 35.0% of revenue after the direct cost of what it sells.
- **Operating margin: 19.3%**. 19.3% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 15.2%**. 15.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 15.5%**. 15.5% on shareholders' equity is solid.
- **Return on invested capital: 18.1%**. Return on all capital, debt included, is 18.1%: comfortably above what that capital costs.
- **Return on assets: 13.9%**. Each dollar of assets produces 13.9% of profit.

## Growth
- **Revenue growth (1 yr): 9.6%** (3-yr 9.7%/yr, 5-yr 8.5%/yr). Revenue grew 9.6% over the last year, against 8.5% a year compounded over five years.
- **EPS growth (1 yr): -1.1%** (3-yr 8.6%/yr, 5-yr 4.3%/yr). Earnings per share fell 1.1%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 33.7%/yr**. Free cash flow has compounded at 33.7% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Gentex Corporation holds more cash than debt.
- **Current ratio: 2.91** (quick 2.91). Current assets cover the next year's liabilities 2.91 times.
- **Altman Z-score: 8.69**. A Z-score of 8.69 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 2.39%** ($0.48 per share, trailing). Gentex Corporation yields 2.39%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 28%** (21% of free cash flow). 28% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 19**. 19 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 0.2%/yr** (1-yr 0.0%). The dividend has grown 0.2% a year over five years.

## Analyst view
- **Analyst consensus: hold** (9 analysts). 9 analysts cover Gentex Corporation; the consensus is hold, with an average price target of $25.28 (+26% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -10.9%** (YTD -10.3%, 3-mo -12.3%). The shares are down 10.9% over twelve months including dividends.
- **From 52-week high: -24.2%** (1.7% above the low). Trading 24% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 44**. An RSI of 44 is neutral.
- **Beta (1 yr): 0.72** (volatility 25%). Beta of 0.72 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=GNTX · Page: https://foliofundamentals.com/stocks/gntx

Not investment advice.